Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
Novartis
Queensland Health
Julphar
Boehringer Ingelheim
Healthtrust
Baxter
Merck
Argus Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Sulfadiazine - Generic Drug Details

« Back to Dashboard

What are the generic sources for sulfadiazine and what is the scope of sulfadiazine freedom to operate?

Sulfadiazine
is the generic ingredient in three branded drugs marketed by Abbvie, Everylife, Impax Labs, Lannett, Lederle, Lilly, and Sandoz, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for sulfadiazine. One supplier is listed for this compound.

Pharmacology for sulfadiazine

Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial

Medical Subject Heading (MeSH) Categories for sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LillySULFADIAZINEsulfadiazineTABLET;ORAL004122-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
EverylifeSULFADIAZINEsulfadiazineTABLET;ORAL080088-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LillySULFONAMIDES DUPLEXsulfadiazine; sulfamerazineSUSPENSION;ORAL006317-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax LabsSULFADIAZINEsulfadiazineTABLET;ORAL080081-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieSULFADIAZINEsulfadiazineTABLET;ORAL004125-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettSULFADIAZINEsulfadiazineTABLET;ORAL080084-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LederleSULFADIAZINE SODIUMsulfadiazine sodiumINJECTABLE;INJECTION004054-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozSULFADIAZINEsulfadiazineTABLET;ORAL040091-001Jul 29, 1994RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
LederleSULFADIAZINEsulfadiazineTABLET;ORAL004054-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Citi
McKinsey
Cantor Fitzgerald
US Army
Novartis
Fish and Richardson
Chubb
Healthtrust
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot